Sean Matthews
Waver, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide.
Journal: Infectious diseases and therapy
Published: January 13, 2025
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
Journal: Influenza and other respiratory viruses
Published: May 22, 2023
An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies.
Journal: The Clinical journal of pain
Published: December 08, 2022
Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study.
Journal: Open forum infectious diseases
Published: October 27, 2022
Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials.
Journal: Infectious diseases and therapy
Published: June 29, 2022
An Easy-to-Implement Clinical-Trial Frailty Index Based on Accumulation of Deficits: Validation in Zoster Vaccine Clinical Trials.
Journal: Clinical interventions in aging
Published: March 10, 2022
Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.
Journal: Human vaccines & immunotherapeutics
Published: December 14, 2021
Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study.
Journal: Advances in therapy
Published: December 22, 2020
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
Journal: Journal of the American Geriatrics Society
Published: July 31, 2020
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: February 12, 2020
Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: June 17, 2019
Evaluation of two frailty indices, with practical application in a vaccine clinical trial.
Journal: Human vaccines & immunotherapeutics
Published: June 04, 2019
Last Updated: 09/26/2026